Natco Pharma Limited Buyback Offer 2018
Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has seven manufacturing facilities spread across India with dedicated modern research laboratories, capabilities in New Drug Development, etc.
Natco family currently consists of more than 4000 employees, we are consistently ranked among fastest growing pharmaceutical companies in India. Natco is well recognized for its innovation in Pharmaceutical R&D.
The Company’s strength in research and people has been the cornerstone of its success, sustaining large investments in research initiatives of Rs.322 crores during the five years leading to FY17.
The Company is opportunity-driven, responding to new ideas and developments with industrial discipline on the one hand and strategic flexibility on the other.
The Company is integrated across the value chain – APIs to formulations – in the manufacture of select products leading to corresponding advantages in terms of cost, quality and logistics.
Buy Back Offer Deal:
|Buyback Type:||Open Market|
|Buyback Opening Date:||Nov 19 2018|
|Buyback Closing Date:||May 18 2019|
|Buyback Offer Amount:||₹ 250 Cr|
|Date of Board Meeting approving the proposal:||Nov 05 2018|
|Date of Public Announcement:||Nov 05 2018|
|Buyback Offer Size:||8.10%|
|Buyback Price:||₹ 1000 Per Equity Share|
Details of Buyback:
Shareholding Pattern Pre and Post buyback:
|Particulars||Pre Buyback as on November||Post Buyback|
|Category of Share Holder||No. of Equity Share||%||No. of Equity Share||%|
|Promoters and Promoter Group||8,90,81,645||48.25||8,90,81,645||48.91|
|Indian Public/Clearing member/IEPF/Trusts||3,29,52,358||17.85|
|NRIs/ Foreign Nationals/Overseas Body Corporate||14,15,160||0.77|